ALLIANCEBERNSTEIN L.P. - INSYS THERAPEUTICS INC NEW ownership

INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 37 filers reported holding INSYS THERAPEUTICS INC NEW in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of INSYS THERAPEUTICS INC NEW
ValueSharesWeighting
Q1 2019$515,000
+39.2%
111,520
+5.5%
0.00%
Q4 2018$370,000
-65.3%
105,7200.0%0.00%
-100.0%
Q3 2018$1,066,000
+39.3%
105,7200.0%0.00%0.0%
Q2 2018$765,000
+46.3%
105,720
+22.2%
0.00%
Q1 2018$523,000
-27.2%
86,520
+15.9%
0.00%
-100.0%
Q4 2017$718,000
+18.9%
74,620
+9.7%
0.00%
Q3 2017$604,000
-66.1%
68,020
-51.7%
0.00%
-100.0%
Q2 2017$1,782,000
+175.0%
140,840
+128.6%
0.00%0.0%
Q1 2017$648,000
+35.0%
61,620
+18.0%
0.00%
Q4 2016$480,000
-74.2%
52,220
-66.9%
0.00%
-100.0%
Q3 2016$1,858,000
+134.9%
157,550
+157.8%
0.00%
+100.0%
Q2 2016$791,000
-16.1%
61,120
+3.6%
0.00%0.0%
Q1 2016$943,000
-31.1%
58,970
+23.3%
0.00%0.0%
Q4 2015$1,369,000
+0.6%
47,8200.0%0.00%0.0%
Q3 2015$1,361,000
-33.9%
47,820
-16.5%
0.00%
-50.0%
Q2 2015$2,058,000
+49.3%
57,300
+141.8%
0.00%
+100.0%
Q1 2015$1,378,000
+33.4%
23,700
-3.3%
0.00%0.0%
Q4 2014$1,033,000
-11.5%
24,500
-18.6%
0.00%0.0%
Q3 2014$1,167,000
+4.1%
30,100
-16.2%
0.00%0.0%
Q2 2014$1,121,000
-96.1%
35,900
-94.8%
0.00%
-96.0%
Q1 2014$28,429,000
+11845.0%
686,182
+11079.2%
0.02%
Q4 2013$238,000
+815.4%
6,138
+731.7%
0.00%
Q3 2013$26,000
+52.9%
738
-41.5%
0.00%
Q2 2013$17,0001,2620.00%
Other shareholders
INSYS THERAPEUTICS INC NEW shareholders Q2 2013
NameSharesValueWeighting ↓
Orbimed Advisors 5,406,844$52,014,0000.66%
ETF MANAGERS GROUP, LLC 282,268$3,255,0000.24%
Mirae Asset Global Investments Co., Ltd. 1,470,996$14,151,0000.19%
Financial Gravity Companies, Inc. 4,467$42,0000.05%
GSA CAPITAL PARTNERS LLP 67,200$646,0000.04%
TCI Wealth Advisors, Inc. 7,766$75,0000.03%
Freedom Investment Management, Inc. 64,741$623,0000.03%
GAM Holding AG 83,940$808,0000.02%
SFMG, LLC 11,994$115,0000.02%
SHELL ASSET MANAGEMENT CO 95,127$915,0000.02%
View complete list of INSYS THERAPEUTICS INC NEW shareholders